Epstein-Barr virus microRNA expression increases aggressiveness of solid malignancies

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Pandya, Deep ^a   Mariani, Marisa ^a   He, Shiquan ^a   Andreoli, Mirko ^a   Spennato, Manuela ^a   Dowell Martino, Candice ^a   Fiedler, Paul ^a   Ferlini, Cristiano ^a  

^a DANBURY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; MICRORNA; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; VIRUS RNA;

ARTICLE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PHENOTYPE; RNA SEQUENCE; SOLID TUMOR; TUMOR ESCAPE; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; NEOPLASM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

DISEASE PROGRESSION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; NEOPLASMS; RNA, VIRAL;

EID: 84945533248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136058     Document Type: Article

References (26)

1. Elgar G, Vavouri T. Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends in genetics: TIG. 2008; 24(7):344-52. Epub 2008/06/03. doi: 10.1016/j.tig.2008.04.005 PMID: 18514361.
2. Esteban MA, Bao X, Zhuang Q, Zhou T, Qin B, Pei D. The mesenchymal-to-epithelial transition in somatic cell reprogramming. Current opinion in genetics & development. 2012; 22(5):423-8. Epub 2012/10/23. doi: 10.1016/j.gde.2012.09.004 PMID: 23084025.
3. Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med. 2013; 64:20-30. Epub 2013/05/29. doi: 10.1016/j.freeradbiomed.2013.05.022 PMID: 23712003; PubMed Central PMCID: PMC3762925.
4. Prislei S, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, et al. MiR-200c and HuR in ovarian cancer. BMC Cancer. 2013; 13:72. Epub 2013/02/12. doi: 10.1186/1471-2407-13-72 1471-2407-13-72 [pii]. PMID: 23394580; PubMed Central PMCID: PMC3576328.
5. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, et al. Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer. Molecular therapy: the journal of the American Society of Gene Therapy. 2014; 22(8):1494-503. Epub 2014/05/06. doi: 10.1038/mt.2014.79 PMID: 24791940.
6. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005; 353 (17):1793-801. Epub 2005/10/28. 353/17/1793 [pii] doi: 10.1056/NEJMoa050995 PMID: 16251535.
7. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. Epub 2006/10/25. nrc1997 [pii] doi: 10.1038/nrc1997 PMID: 17060945.
8. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10 (10):704-14. Epub 2009/09/19. nrg2634 [pii] doi: 10.1038/nrg2634 PMID: 19763153.
9. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic acids research. 2006; 34(Database issue):D140-4. Epub 2005/12/31. doi: 10.1093/nar/gkj112 PMID: 16381832; PubMed Central PMCID: PMC1347474.
10. Miller CS, Berger JR, Mootoor Y, Avdiushko SA, Zhu H, Kryscio RJ. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Journal of clinical microbiology. 2006; 44(7):2409-15. Epub 2006/07/11. doi: 10. 1128/JCM.00256-06 PMID: 16825357; PubMed Central PMCID: PMC1489493.
11. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome research. 2008; 18(4):610-21. Epub 2008/02/21. doi: 10.1101/gr.7179508 PMID: 18285502; PubMed Central PMCID: PMC2279248.
12. Pandya D, Mariani M, McHugh M, Andreoli M, Sieber S, He S, et al. Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer. PLoS One. 2014; 9(12):e114750. Epub 2014/12/09. doi: 10.1371/journal.pone.0114750 PMID: 25485872.
13. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research. 2013; 41(Database issue):D377-86. Epub 2012/11/30. doi: 10.1093/nar/gks1118 PMID: 23193289; PubMed Central PMCID: PMC3531194.
14. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC. Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture. Journal of virology. 2013; 87(12):6589-603. Epub 2013/03/29. doi: 10.1128/JVI.00504-13 PMID: 23536669; PubMed Central PMCID: PMC3676078.
15. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513(7517):202-9. Epub 2014/08/01. doi: 10.1038/nature13480. PMID: 25079317; PubMed Central PMCID: PMC4170219.
16. Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 1990; 3(3):377-80. Epub 1990/05/01. PMID: 2163534.
17. Topalian SL, Drake CG, Pardoll DM. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy. Cancer Cell. 2015; 27(4):450-61. Epub 2015/04/11. doi: 10.1016/j.ccell. 2015.03.001 PMID: 25858804; PubMed Central PMCID: PMC4400238.
18. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013; 31:51-72. Epub 2012/11/20. doi: 10.1146/annurev-immunol-032712-100008 PMID: 23157435.
19. Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. Journal of clinical pathology. 2005; 58(10):1096-100. Epub 2005/09/29. doi: 10.1136/jcp.2004.025072 PMID: 16189158; PubMed Central PMCID: PMC1770745.
20. Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R, Bermudez-Morales V, Peralta-Zaragoza O, Hernandez-Pando R, et al. In vivo expression of immunosuppressive cytokines in human papillomavirustransformed cervical cancer cells. Viral Immunol. 2006; 19(3):481-91. Epub 2006/09/22. doi: 10.1089/vim.2006.19.481 PMID: 16987066.
21. Torres-Poveda K, Burguete-Garcia AI, Cruz M, Martinez-Nava GA, Bahena-Roman M, Ortiz-Flores E, et al. The SNP at-592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development. Infectious agents and cancer. 2012; 7(1):32. Epub 2012/11/15. doi: 10.1186/1750-9378-7-32 PMID: 23148667; PubMed Central PMCID: PMC3552694.
22. Diaz-Benitez CE, Navarro-Fuentes KR, Flores-Sosa JA, Juarez-Diaz J, Uribe-Salas FJ, Roman-Basaure E, et al. CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. J Clin Immunol. 2009; 29(4):532-44. Epub 2009/03/05. doi: 10.1007/s10875-009-9279-7 PMID: 19259799.
23. Rigopoulou EI, Abbott WG, Haigh P, Naoumov NV. Blocking of interleukin-10 receptor - A novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin Immunol. 2005; 117 (1):57-64. Epub 2005/07/12. doi: 10.1016/j.clim.2005.06.003 PMID: 16006191.
24. Marquitz AR, Mathur A, Shair KH, Raab-Traub N. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109(24):9593-8. Epub 2012/06/01. doi: 10.1073/pnas.1202910109 PMID: 22647604; PubMed Central PMCID: PMC3386136.
25. Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang M, et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene. 2014; 33 (37):4568-78. Epub 2014/03/26. doi: 10.1038/onc.2014.32 PMID: 24662831; PubMed Central PMCID: PMC4162460.
26. Ationu A, Humphries A, Lalloz MR, Arya R, Wild B, Warrilow J, et al. Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells. Blood. 1999; 94(9):3193-8. Epub 1999/11/11. PMID: 10556207.